Please use this identifier to cite or link to this item: http://hdl.handle.net/10400.6/558
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGil-Longo, Josépt
dc.contributor.authorLaguna, Maria de los Reyespt
dc.contributor.authorVerde, Ignaciopt
dc.contributor.authorCastro, Maria Elenapt
dc.contributor.authorOrallo, Franciscopt
dc.contributor.authorFontenla, José Angelpt
dc.contributor.authorCalleja, José Mariapt
dc.contributor.authorRavina, Enriquept
dc.contributor.authorTeran, Carmenpt
dc.date.accessioned2010-04-28T10:06:49Z-
dc.date.available2010-04-28T10:06:49Z-
dc.date.issued1993-
dc.identifier.urihttp://hdl.handle.net/10400.6/558-
dc.description.abstract3-Hydrazinocycloheptyl[1,2-c]pyridazine (4) and its hydrazone derivatives 3-[N1-(isopropylidene)]hydrazinocycloheptyl[1,2-c]pyridazine [correction of hydrazinocyclohexyl] (5) and 3-[N1-(isobutylidene)]hydrazinocycloheptyl[1,2-c]pyridazine (6) were prepared, and their activity against genetic, neurogenically-induced, and deoxycorticosterone acetate -NaCl-induced hypertension was found to be at least as great as that of hydralazine. The results of studying vasorelaxation of rat aorta by 4 and hydralazine suggest that both these compounds owe their antihypertensive activity to direct relaxation of vascular smooth muscle.-
dc.languageeng-
dc.rightsopenAccess-
dc.titlePyridazine derivatives. XI: Antihypertensive activity of 3-hydrazinocycloheptyl[1,2-C]pyridazine and its hydrazone derivativespt
dc.typearticlept
degois.publication.issue82:286-90pt
degois.publication.titleJournal of Pharmaceutical Sciencespt
Appears in Collections:FCS - DCM | Documentos por Auto-Depósito

Files in This Item:
File Description SizeFormat 
t01027pdf.pdf813,08 kBAdobe PDFView/Open


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote 

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.